罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

idifarma desarrollo farmaceutico s.l. - spania - talidomidum - caps. - 50mg - imunosupresoare alte imunosupresoare

欧盟 - 罗马尼亚文 - EMA (European Medicines Agency)

novartis ireland ltd - ofatumumab - scleroză multiplă, scleroză multiplă recurent-remisivă - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.

罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 10mg - imunosupresoare alte imunosupresoare

罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 15mg - imunosupresoare alte imunosupresoare

罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 20mg - imunosupresoare alte imunosupresoare

罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 5mg - imunosupresoare alte imunosupresoare

罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

sun pharmaceutical industries europe b.v. - olanda - lenalidomidum - caps. - 7,5mg - imunosupresoare alte imunosupresoare

欧盟 - 罗马尼亚文 - EMA (European Medicines Agency)

lipomed gmbh - thalidomide - mielom multiplu - imunosupresoare - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy. thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.

欧盟 - 罗马尼亚文 - EMA (European Medicines Agency)

neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - imunosupresoare - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.

摩尔多瓦 - 罗马尼亚文 - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

menarini international operations luxembourg sa - dexketoprofenum - granule pentru solutie orala - 25 mg